Prospects of using the genetically engineered preparation dupilumab for the treatment of atopic dermatitis in the adult population. J Pak Assoc Dermatol [Internet]. 2022 Jun. 1 [cited 2026 Aug. 24];32(2):327-33. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1900